Literature DB >> 27980287

A case of neurosyphilis presenting with limbic encephalitis.

Kazuto Tsukita1, Akihiro Shimotake, Mitsuyoshi Nakatani, Yukitoshi Takahashi, Akio Ikeda, Ryosuke Takahashi.   

Abstract

A 46-year-old man presented with a history of personality change and memory disturbance for 5 months. He gradually became difficult in doing a daily job. Brain MRI showed abnormal hyperintensity within bilateral mesial temporal lobes on T2 weighted image. Therefore, viral and autoimmune limbic encephalitis was initially suspected. However, because treponemal and non-treponemal specific antibodies were positive in serum and cerebrospinal fluid (CSF), the diagnosis of neurosyphilis was made. Patients of neurosyphilis with mesiotemporal T2 weighted hyperintensity reportedly showed common features such as relatively young age, HIV-negative, subacute cognitive impairment and seizure, as seen in our patient. Neurosyphilis should be included in the differential diagnosis for mesiotemporal abnormality in patients with these features. In addition, in our patient, anti-glutamate receptor ε2 antibody (ELISA) was strongly positive in CSF that suggested additional autoimmune pathophysiological mechanism.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27980287     DOI: 10.5692/clinicalneurol.cn-000936

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Cryptococcus Meningitis Can Co-occur with Anti-NMDA Receptor Encephalitis.

Authors:  Yusuke Sakiyama; Eiji Matsuura; Ayano Shigehisa; Yuki Hamada; Mika Dozono; Satoshi Nozuma; Tomonori Nakamura; Keiko Higashi; Akihiro Hashiguchi; Yukitoshi Takahashi; Hiroshi Takashima
Journal:  Intern Med       Date:  2020-06-09       Impact factor: 1.271

2.  Autoimmune Encephalitis in Long-Standing Schizophrenia: A Case Report.

Authors:  Amy Vaux; Karen Robinson; Burcu Saglam; Nathan Cheuk; Trevor Kilpatrick; Andrew Evans; Mastura Monif
Journal:  Front Neurol       Date:  2022-02-11       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.